ventureMed is an innovator in vessel preparation and drug delivery for the interventional treatment of peripheral artery disease (PAD). The company’s technologies make vessel preparation simpler, quicker and more cost-effective. VentureMed offers interventionalists and their patients around the world state-of-the-art devices for treating long, complicated lesions in PAD. Founded by a vascular surgeon, VentureMed is committed to improving patient and economic outcomes.
FLEX® - an innovative one size fits all platform for plaque modification and intravascular drug-delivery.
Learn more about FLEX here.
ISO 13485 Certification
CE Mark Approved
FLEX has received FDA clearance and is available for sale in the U.S.